Goal guide

Peptides for muscle growth

Most peptides discussed for muscle growth are not muscle-builders in the way anabolic steroids are. They are growth-hormone secretagogues that nudge the body to release more of its own growth hormone, or recovery peptides aimed at training back sooner. The honest framing is that human evidence for building muscle is limited for almost all of them.

Reviewed for accuracy · Last reviewed July 8, 2026

What peptides are studied for muscle growth?

The compounds below are the ones most discussed for muscle growth. Each links to its full profile, where the dosing, side effects, and sources live. They are ordered roughly by how much human evidence sits behind them, not by a claim that any one works.

CJC-1295 / Ipamorelin
The most discussed growth-hormone secretagogue pairing: a GHRH analog plus a selective GH secretagogue. Human evidence for body composition is limited, and neither is FDA-approved.
Sermorelin
A GHRH analog that stimulates the pituitary's own GH release. Its clinical record is in growth-hormone deficiency, not muscle building, so muscle-focused use is off-label and thinly evidenced.
Tesamorelin
FDA-approved to reduce visceral fat in a specific population. It raises GH and IGF-1, which is why it appears in muscle discussions, but its trials measured fat, not muscle growth.
MOTS-c
A mitochondrial-derived peptide studied for metabolism and exercise capacity, mostly in animals. Relevant to training performance in theory, but human muscle-growth evidence is essentially absent.
BPC-157
Not a muscle-builder, but frequently used for recovery from training injuries so people can train consistently. Its evidence is mostly animal, and it is not FDA-approved.
MK-677 (Ibutamoren)
An oral ghrelin-receptor agonist that reliably raises GH and IGF-1, but its trials did not show gains in strength or physical function. A biomarker rise is not the same as muscle growth, and it is not FDA-approved.
CJC-1295
A GHRH analog that raises the body's own GH, often paired with a GHRP. Its substantial human data is a small pharmacokinetic study, so muscle-specific evidence is essentially absent, and it is not FDA-approved.
Hexarelin
A potent GHRP with real human GH-release data, but no trials measuring muscle growth, and its effect tends to desensitize with continued use. Not FDA-approved.
IGF-1 LR3
A long-acting IGF-1 analog used anecdotally in bodybuilding, but with no human trials for muscle, an uncharacterized safety profile, and a theoretical cancer-signaling concern. Research chemical only.

What to weigh

The recurring theme across these is that the growth-hormone pathway is indirect: a secretagogue raises GH, and any effect on muscle depends on many other factors, from training and nutrition to sleep. None of these peptides has strong human trial evidence specifically for building muscle.

Several are also relevant to drug-tested athletes, since GH secretagogues are covered by anti-doping rules. And apart from tesamorelin, the compounds here are research-only, so product quality is a real-world variable on top of the biological uncertainty.

FAQ

What is the best peptide for muscle growth?There is no clear evidence-based winner, and no peptide here has strong human data specifically for building muscle. The growth-hormone secretagogues (CJC-1295, ipamorelin, sermorelin) are the most discussed, but their effects on muscle are indirect and not well established in humans.
Do muscle-growth peptides actually work?Honestly, the human evidence is limited. Most raise growth hormone rather than acting on muscle directly, and rigorous trials measuring muscle growth are largely absent. Treat strong before-and-after claims with caution.

References

  1. Ipamorelin, the first selective growth hormone secretagogueEuropean Journal of Endocrinology · 1998 · PMID 9849822 · DOI 10.1530/eje.0.1390552
  2. Metabolic effects of a growth hormone-releasing factor in patients with HIVNew England Journal of Medicine · 2007 · PMID 18057338 · DOI 10.1056/NEJMoa072375
  3. Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults: A Randomized TrialAnnals of Internal Medicine · 2008 · PMID 18981485 · DOI 10.7326/0003-4819-149-9-200811040-00003
  4. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsJournal of Clinical Endocrinology & Metabolism · 2006 · PMID 16352683 · DOI 10.1210/jc.2005-1536
  5. Growth Hormone-Releasing Activity of Hexarelin, a New Synthetic Hexapeptide, After Intravenous, Subcutaneous, Intranasal, and Oral Administration in ManJournal of Clinical Endocrinology & Metabolism · 1994 · PMID 8126144 · DOI 10.1210/jcem.78.3.8126144

This page is an independent educational reference and is not medical advice, and does not indicate any approval status for any use. Talk to a doctor before starting any compound.